1. Home
  2. KYMR vs SOLS Comparison

KYMR vs SOLS Comparison

Compare KYMR & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$104.20

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Solstice Advanced Materials Inc.

SOLS

Solstice Advanced Materials Inc.

HOLD

Current Price

$63.45

Market Cap

9.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
SOLS
Founded
2015
2025
Country
United States
United States
Employees
N/A
4400
Industry
Medicinal Chemicals and Botanical Products
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
KYMR
SOLS
Price
$104.20
$63.45
Analyst Decision
Strong Buy
Buy
Analyst Count
26
4
Target Price
$107.72
$79.25
AVG Volume (30 Days)
558.9K
5.0M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,211,000.00
N/A
Revenue This Year
$10.61
$6.36
Revenue Next Year
$8.17
$5.64
P/E Ratio
N/A
$54.31
Revenue Growth
N/A
N/A
52 Week Low
$36.88
$40.43
52 Week High
$130.05
$90.80

Technical Indicators

Market Signals
Indicator
KYMR
SOLS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
KYMR
SOLS

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

Share on Social Networks: